Ausgabe 1/2019
Inhalt (25 Artikel)
Quality-adjusted life years in glioma patients: a systematic review on currently available data and the lack of evidence-based utilities
Vicki Marie Butenschoen, Anna Kelm, Bernhard Meyer, Sandro M. Krieg
Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas
Shuyu Hao, Guanyou Huang, Jie Feng, Da Li, Ke Wang, Liang Wang, Zhen Wu, Hong Wan, Liwei Zhang, Junting Zhang
CD146 is highly expressed in glioma stem cells and acts as a cell cycle regulator
Toshio Yawata, Youichiro Higashi, Yu Kawanishi, Takahito Nakajo, Naoki Fukui, Hitoshi Fukuda, Tetsuya Ueba
Temporary blood–brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma
Antonin Dréan, Nolwenn Lemaire, Guillaume Bouchoux, Lauriane Goldwirt, Michael Canney, Larissa Goli, Amira Bouzidi, Charlotte Schmitt, Jeremy Guehennec, Maïté Verreault, Marc Sanson, Jean-Yves Delattre, Karima Mokhtari, Frédéric Sottilini, Alexandre Carpentier, Ahmed Idbaih
Disparities among racial/ethnic groups of patients diagnosed with ependymoma: analyses from the Surveillance, Epidemiology and End Results (SEER) registry
Ashley E. Stenzel, Robert A. Fenstermaker, Laura M. Wiltsie, Kirsten B. Moysich
Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT
Gabrielle Truitt, Haley Gittleman, Rebecca Leece, Quinn T. Ostrom, Carol Kruchko, Terri S. Armstrong, Mark R. Gilbert, Jill S. Barnholtz-Sloan
Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma
Yukina Morimoto, Ryota Tamura, Kentaro Ohara, Kenzo Kosugi, Yumiko Oishi, Yuki Kuranari, Kazunari Yoshida, Masahiro Toda
Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients
Bas Weenink, Mandy van Brakel, Rebecca Wijers, Peter A. E. Sillevis Smitt, Pim J. French, Reno Debets
Radiotherapy for recurrent intracranial epidermoid cysts without malignant transformation: a single-institution case series
Ramin A. Morshed, Susan Y. Wu, Penny K. Sneed, Michael W. McDermott
Smoking status and perioperative adverse events in patients undergoing cranial tumor surgery
Luis Padevit, Johannes Sarnthein, Martin Nikolaus Stienen, Niklaus Krayenbühl, Oliver Bozinov, Luca Regli, Marian Christoph Neidert
Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma
Leon D. Kaulen, Daniela Galluzzo, Pei Hui, Frank Barbiero, Philipp Karschnia, Anita Huttner, Robert Fulbright, Joachim M. Baehring
Outcomes after craniotomy for resection of craniopharyngiomas in adults: analysis of the National Surgical Quality Improvement Program (NSQIP)
Andrew K. Rock, Alper Dincer, Matthew T. Carr, Charles F. Opalak, Kathryn G. Workman, William C. Broaddus
Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study
Haihui Jiang, Wei Zeng, Xiaohui Ren, Yong Cui, Mingxiao Li, Kaiyuan Yang, Mohammad Elbaroody, Song Lin
Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma
Junmei Wang, Zhaoxia Liu, Yun Cui, Yuqing Liu, Jingyi Fang, Li Xu, Yanjiao He, Jiang Du, Yujin Su, Wanjing Zou, Zuolin Xu, Guilin Li
Growth rate and fate of untreated hemangioblastomas: clinical assessment of the experience of a single institution
Joonho Byun, Hee Jun Yoo, Jeong Hoon Kim, Young Hoon Kim, Young Hyun Cho, Seok Ho Hong, Chang Jin Kim
Awake surgery for glioblastoma can preserve independence level, but is dependent on age and the preoperative condition
Riho Nakajima, Masashi Kinoshita, Hirokazu Okita, Tetsutaro Yahata, Mitsutoshi Nakada
Patterning of corpus callosum integrity in glioma observed by MRI: Effect of 2D bi-axial lamellar brain architecture
Vikas Pareek, Subhadip Paul, V. P. Subramanyam Rallabandi, Prasun K. Roy
Primary central nervous system tumor treatment and survival in the United States, 2004–2015
Catherine R. Garcia, Stacey A. Slone, Therese A. Dolecek, Bin Huang, Janna H. Neltner, John L. Villano
Predictive modeling of brain tumor laser ablation dynamics
Walter J. Jermakowicz, Anil K. Mahavadi, Iahn Cajigas, Lia Dan, Santiago Guerra, Ghulam Farooq, Ashish H. Shah, Pierre F. D’Haese, Michael E. Ivan, Jonathan R. Jagid, Ricardo J. Komotar
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma
Andrew B. Lassman, Kenneth D. Aldape, Peter J. Ansell, Earle Bain, Walter J. Curran, Marica Eoli, Pim J. French, Manabu Kinoshita, Jim Looman, Minesh Mehta, Yoshihiro Muragaki, Yoshitaka Narita, Christopher Ocampo, Lisa Roberts-Rapp, Minghao Song, Michael A. Vogelbaum, Annemiek M. E. Walenkamp, Tony J. C. Wang, Peixin Zhang, Martin J. van den Bent
Phase II study of weekly carboplatin in pretreated adult malignant gliomas
Veronica Villani, Andrea Pace, Antonello Vidiri, Antonio Tanzilli, Francesca Sperati, Irene Terrenato, Carosi Mariantonia, Beatrice Casini, Giulio Metro, Marta Maschio, Koudriavtseva Tatiana, Francesco Cognetti, Alessandra Fabi
Primary or salvage stereotactic radiosurgery for brain metastatic small cell lung cancer
Andrew Faramand, Ajay Niranjan, Hideyuki Kano, John Flickinger, L. Dade Lunsford
Central nervous system neuroblastoma metastases pseudoprogression following intraventricular anti-B7-H3 radioimmunotherapy
Kim Kramer, Osman Khan, Sofia Haque
A novel finding of an IDH2 mutation in an interesting adult Sonic Hedgehog mutated medulloblastoma
Elena I. Fomchenko, E. Zeynep Erson-Omay, Jennifer Moliterno
A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials
Saba S. Shaikh, Priya U. Kumthekar, Nisha A. Mohindra